Doctronic logo spinning
Skipping wait room
AI Doctor ready
Starting secure consult

Innovative Medical Devices for Hemophilia Care

Published: Sep 11, 2023

Medical devices are revolutionizing hemophilia care, making treatment more effective and convenient.
Contents

Central Venous Catheters

Central venous catheters are essential for administering clotting factor infusions, especially in young children. They provide reliable venous access, reducing the trauma of repeated needle insertions. However, they come with risks such as infection and thrombosis, requiring careful management and monitoring.

Factor Infusion Pumps

Infusion pumps are a convenient way to deliver clotting factors, ensuring accurate dosing and timing. These portable devices allow for home treatment, promoting independence and flexibility. Patients and caregivers must be trained in their use to ensure safety and effectiveness.
Medical devices such as central venous catheters and infusion pumps are revolutionizing hemophilia care by providing effective and convenient treatment options.

The Rise of Emicizumab

Emicizumab is a breakthrough treatment administered subcutaneously, reducing the need for frequent factor infusions. Its ease of use and effectiveness in preventing bleeding make it a valuable option for many patients. Understanding its administration and monitoring is crucial for optimal outcomes.

Frequently Asked Questions

It's a device for reliable venous access used in administering clotting factors.

They deliver accurate doses of clotting factors, allowing home treatment.

A subcutaneous treatment reducing the need for frequent factor infusions.

Yes, risks include infection and thrombosis with catheters.

The Bottom Line

Innovative devices and treatments are enhancing hemophilia care, offering greater convenience and effectiveness.
Learn more about these medical devices by consulting with Doctronic.

Related Articles

References

  1. Journeycake JM, Quinn CT, Miller KL, et al. Catheter-related deep venous thrombosis in children with hemophilia. Blood 2001; 98:1727.
  2. Adcock DM, Strandberg K, Shima M, Marlar RA. Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B. Int J Lab Hematol 2018; 40:621.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
sthetoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely